AU537378B2 - Creación de Inventos y Patentes con Inteligencia Artificial

AU537378B2 – Naphthimidazole and naphthoxazoles
– Google Patents

AU537378B2 – Naphthimidazole and naphthoxazoles
– Google Patents
Naphthimidazole and naphthoxazoles

Info

Publication number
AU537378B2

AU537378B2
AU71881/81A
AU7188181A
AU537378B2
AU 537378 B2
AU537378 B2
AU 537378B2
AU 71881/81 A
AU71881/81 A
AU 71881/81A
AU 7188181 A
AU7188181 A
AU 7188181A
AU 537378 B2
AU537378 B2
AU 537378B2
Authority
AU
Australia
Prior art keywords
naphthoxazoles
naphthimidazole
Prior art date
1980-02-08
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)

Ceased

Application number
AU71881/81A
Other versions

AU7188181A
(en

Inventor
Amedeo Omodei Sale
Emilio Toia
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Gruppo Lepetit SpA

Original Assignee
Gruppo Lepetit SpA
Lepetit SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
1980-02-08
Filing date
1981-06-16
Publication date
1984-06-21

1981-01-12
Priority to EP81100152A
priority
Critical
patent/EP0034249B1/en

1981-01-12
Priority to AT81100152T
priority
patent/ATE9999T1/en

1981-01-30
Priority to US06/230,135
priority
patent/US4360674A/en

1981-02-05
Priority to JP1511481A
priority
patent/JPS56125374A/en

1981-02-06
Priority to CA000370348A
priority
patent/CA1165762A/en

1981-06-16
Application filed by Gruppo Lepetit SpA, Lepetit SpA
filed
Critical
Gruppo Lepetit SpA

1981-06-16
Priority to AU71881/81A
priority
patent/AU537378B2/en

1982-04-26
Priority to US06/371,768
priority
patent/US4461894A/en

1982-12-23
Publication of AU7188181A
publication
Critical
patent/AU7188181A/en

1984-06-21
Application granted
granted
Critical

1984-06-21
Publication of AU537378B2
publication
Critical
patent/AU537378B2/en

2001-06-16
Anticipated expiration
legal-status
Critical

Status
Ceased
legal-status
Critical
Current

Links

Espacenet

Global Dossier

Discuss

Classifications

C—CHEMISTRY; METALLURGY

C07—ORGANIC CHEMISTRY

C07D—HETEROCYCLIC COMPOUNDS

C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings

C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems

A—HUMAN NECESSITIES

A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE

A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

A61P25/00—Drugs for disorders of the nervous system

C—CHEMISTRY; METALLURGY

C07—ORGANIC CHEMISTRY

C07D—HETEROCYCLIC COMPOUNDS

C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings

C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems

C07D263/60—Naphthoxazoles; Hydrogenated naphthoxazoles

AU71881/81A
1980-02-08
1981-06-16
Naphthimidazole and naphthoxazoles

Ceased

AU537378B2
(en)

Priority Applications (7)

Application Number
Priority Date
Filing Date
Title

EP81100152A

EP0034249B1
(en)

1980-02-08
1981-01-12
New naphthimidazole and naphthoxazole derivatives, their preparation, and their use in pharmaceuticals

AT81100152T

ATE9999T1
(en)

1980-02-08
1981-01-12

NAPHTHIMIDAZOLE AND NAPHTHOXAZOLE DERIVATIVES, THEIR PRODUCTION AND USE IN PHARMACEUTICALS.

US06/230,135

US4360674A
(en)

1980-02-08
1981-01-30
Naphth[1,2-d]imidazoles

JP1511481A

JPS56125374A
(en)

1980-02-08
1981-02-05
Novel naphthoimidazole and naphthoxazole derivatives, their manufacture and their use as medicinal goods

CA000370348A

CA1165762A
(en)

1980-02-08
1981-02-06
Naphthimidazole and naphthoxazole derivatives their preparation, and their use in pharmaceuticals

AU71881/81A

AU537378B2
(en)

1980-02-08
1981-06-16
Naphthimidazole and naphthoxazoles

US06/371,768

US4461894A
(en)

1980-02-08
1982-04-26
Naphth[1,2-d]imidazoles

Applications Claiming Priority (2)

Application Number
Priority Date
Filing Date
Title

GB8004311

1980-02-08

AU71881/81A

AU537378B2
(en)

1980-02-08
1981-06-16
Naphthimidazole and naphthoxazoles

Publications (2)

Publication Number
Publication Date

AU7188181A

AU7188181A
(en)

1982-12-23

AU537378B2
true

AU537378B2
(en)

1984-06-21

Family
ID=25636747
Family Applications (1)

Application Number
Title
Priority Date
Filing Date

AU71881/81A
Ceased

AU537378B2
(en)

1980-02-08
1981-06-16
Naphthimidazole and naphthoxazoles

Country Status (5)

Country
Link

US
(2)

US4360674A
(en)

EP
(1)

EP0034249B1
(en)

JP
(1)

JPS56125374A
(en)

AU
(1)

AU537378B2
(en)

CA
(1)

CA1165762A
(en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party

Publication number
Priority date
Publication date
Assignee
Title

EP0034249B1
(en)

1980-02-08
1984-10-24
Gruppo Lepetit S.P.A.
New naphthimidazole and naphthoxazole derivatives, their preparation, and their use in pharmaceuticals

US4368201A
(en)

1981-07-20
1983-01-11
Usv Pharmaceutical Corporation
Tetrahydronaphthoxazoles

GB8403141D0
(en)

1984-02-07
1984-03-14
Lepetit Spa
Imidazole derivatives

IL97144A
(en)

1990-02-27
1994-11-28
Erba Carlo Spa
Substituted 1-(alkoxy-iminoalkyl)imidazole derivatives, their preparation and pharmaceutical compositions containing them

US5750542A
(en)

1993-09-28
1998-05-12
Pfizer
Benzisoxazole and benzisothizole derivatives as cholinesterase inhibitors

WO1994003439A1
(en)

1992-07-29
1994-02-17
Agouron Pharmaceuticals, Inc.
Antiproliferative tricyclic compounds

DE69413523T2
(en)

1993-03-18
1999-05-12
Merck Sharp & Dohme

BENZIMIDAZOLE DERIVATIVES

EP0809641A1
(en)

1995-02-15
1997-12-03
Neurogen Corporation
Certain bridged 4-phenyl-2-aminomethylimidazoles; new dopamine receptor subtype specific ligands

US5773616A
(en)

1995-02-15
1998-06-30
Neurogen Corporation
Certain bridged 4-phenyl-2-aminomethylimidazoles; new dopamine receptor subtype specific ligands

WO2009125809A1
(en)

2008-04-11
2009-10-15
第一三共株式会社
Piperidine derivatives

Family Cites Families (3)

* Cited by examiner, † Cited by third party

Publication number
Priority date
Publication date
Assignee
Title

DE2964567D1
(en)

1978-12-21
1983-02-24
Lepetit Spa
New 3h-naphtho(1,2-d)imidazoles, processes for preparing them, compounds for use as antiinflammatory and antimicrobial agents and compositions for that use containing them

US4173634A
(en)

1979-02-23
1979-11-06
E. R. Squibb & Sons, Inc.
Basically-substituted tricyclic pyrazoles useful as antiinflammatory agents

EP0034249B1
(en)

1980-02-08
1984-10-24
Gruppo Lepetit S.P.A.
New naphthimidazole and naphthoxazole derivatives, their preparation, and their use in pharmaceuticals

1981

1981-01-12
EP
EP81100152A
patent/EP0034249B1/en
not_active
Expired

1981-01-30
US
US06/230,135
patent/US4360674A/en
not_active
Expired – Fee Related

1981-02-05
JP
JP1511481A
patent/JPS56125374A/en
active
Granted

1981-02-06
CA
CA000370348A
patent/CA1165762A/en
not_active
Expired

1981-06-16
AU
AU71881/81A
patent/AU537378B2/en
not_active
Ceased

1982

1982-04-26
US
US06/371,768
patent/US4461894A/en
not_active
Expired – Fee Related

Also Published As

Publication number
Publication date

AU7188181A
(en)

1982-12-23

EP0034249B1
(en)

1984-10-24

JPS56125374A
(en)

1981-10-01

US4360674A
(en)

1982-11-23

CA1165762A
(en)

1984-04-17

US4461894A
(en)

1984-07-24

EP0034249A3
(en)

1982-02-24

EP0034249A2
(en)

1981-08-26

JPH0346467B2
(en)

1991-07-16

Información de contacto